Meningitis, Cryptococcal Clinical Trial
Official title:
Evaluation of a Public Health Strategy to Improve Survival of HIV Infected Patients
It is hypothesized that implementing plasma CrAg screening in clinics providing routine HIV care will enable identification of Vietnamese adult patients with advanced HIV (CD4 ≤100 cells/μL) who have early cryptococcal disease, enable prompt preemptive treatment with high-dose fluconazole, and improve survival.
This is multicenter prospective cohort evaluation of the implementation of a cryptococcal antigen (CrAg) screening program in Vietnam. HIV-infected patients with CD4 ≤100 cells/μL who present for HIV care at outpatient clinics (OPCs) in Vietnam where CrAg screening is offered will be recruited into the study. Study participants will be screened for cryptococcal antigen using the Lateral Flow Assay (LFA) and followed up for 12 months with clinical assessments and the collection of routine and supplemental survey data. Those who are CrAg-positive, but have no features of central nervous system (CNS) disease, will be treated with high-dose fluconazole. Those with symptoms of CNS disease will be treated according to national guidelines. Survival, retention in care, and other clinical outcomes will be documented for patients who test CrAg-positive and are treated with fluconazole and those who test CrAg-negative. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00012467 -
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
|
Phase 2 | |
Completed |
NCT00002077 -
An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00002019 -
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
|
N/A | |
Completed |
NCT00002305 -
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00000639 -
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00000677 -
SCH 39304 as Therapy for Acute Cryptococcal Meningitis in HIV-Infected Patients Followed by Maintenance Therapy
|
Phase 1 | |
Completed |
NCT00002040 -
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00002074 -
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
|
N/A | |
Completed |
NCT00002076 -
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00001017 -
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
|
Phase 3 | |
Completed |
NCT00002068 -
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00002113 -
A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
|
N/A | |
Completed |
NCT00002294 -
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
|
N/A | |
Completed |
NCT00002075 -
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00002306 -
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
|
N/A | |
Completed |
NCT00000776 -
Dexamethasone in Cryptococcal Meningitis
|
Phase 2 | |
Completed |
NCT00000708 -
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
|
N/A | |
Completed |
NCT00002316 -
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
|
Phase 1 |